Noesis Capital Mangement Corp Amgen Inc Transaction History

Noesis Capital Mangement Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $565,716 - $625,830	-2,580 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$198.88 - $227.6 $12,330 - $14,111	-62 Reduced 2.35%	2,580 $580,000
Q3 2021 Nov 04, 2021	BUY	$212.27 - $248.7 $560,817 - $657,065	2,642 New	2,642 $561,000
Q1 2018 May 07, 2018	SELL	$169.43 - $198.0 $1.1 Million - $1.29 Million	-6,508 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $230,060 - $257,048	-1,363 Reduced 17.32%	6,508 $1.13 Million

Q3 2017 Nov 07, 2017	SELL	$167.29 - $191.0 $325,880 - $372,068	-1,948 Reduced 19.84%	7,871 $1.47 Million
Q2 2017 Aug 10, 2017	BUY	N/A	9,819	9,819 $1.69 Million

2,934

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Noesis Capital Mangement Corp, based on Form 13F filings with the SEC.

Stay updated on Noesis Capital Mangement Corp with notifications on news.